Baylor Scott and White Research

Temple, Texas 76502

2 studies enrolling now · 3 studies all time

What they study most

C3G, Chronic Myelogenous Leukemia - Chronic Phase, IC-MPGN

Studies at this site

• A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy — Recruiting now
• Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy. — Recruiting now
• Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN — Recruiting now